tiprankstipranks
Replimune Group (REPL)
NASDAQ:REPL
Want to see REPL full AI Analyst Report?

Compare Replimune Group (REPL) vs. Competitors

519 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Replimune Group
$2.17
$960.32M
-3.25
22.94%
1 Buy
5 Hold
2 Sell
Hold
Anavex Life Sciences
$3.64
$242.80M
-5.65
-72.62%
2 Buy
0 Hold
0 Sell
Moderate Buy
Arcus Biosciences
$24.25
$3.90B
-9.79
264.71%
7 Buy
2 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$10.75
$986.52M
-6.62
-9.24%
11 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$17.51
$2.37B
-7.25
93.41%
11 Buy
1 Hold
0 Sell
Strong Buy
Sana Biotechnology
$3.52
$951.76M
-3.68
19.16%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REPL
Replimune Group
11.63
2.34
25.19%
AVXL
Anavex Life Sciences
2.62
-6.60
-71.58%
RCUS
Arcus Biosciences
31.00
22.86
280.84%
ORIC
Oric Pharmaceuticals
9.53
-0.62
-6.11%
NRIX
Nurix Therapeutics
22.90
11.51
101.05%
SANA
Sana Biotechnology
3.42
0.69
25.27%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts